Science
Mechanism of Action
The proposed mechanism of action for Cyclohexylethyl Butyrate on the skin is indirect, relying on its hydrolysis into butyrate. Butyrate is known to exert anti-inflammatory effects by inhibiting cytokine and inflammatory cell production, promoting the proliferation of regulatory T cells (Tregs), and acting as a histone deacetylase inhibitor to modulate gene expression. It also contributes to skin microbiome homeostasis, offers protective effects against infection and ultraviolet radiation, and supports wound healing processes.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
ECHA classifies 1-Cyclohexylethyl butyrate (INCI: CYCLOHEXYLETHYL BUTYRATE) with GHS hazard statements H315 (Causes skin irritation) and H319 (Causes serious eye irritation), with a 94.9% notification ratio for both. This indicates a high likelihood of irritation to both skin and eyes. EWG Skin Deep assigns a 'LOW' concern for cancer, allergies & immunotoxicity, and developmental and reproductive toxicity, and it is not suspected to be persistent or bioaccumulative. No specific CIR or SCCS safety assessments were found.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite the theoretical benefits of its butyrate hydrolysis product, Cyclohexylethyl Butyrate is directly classified as a skin and eye irritant, making it unsuitable for precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…